Chengchao Sun

Chengchao Sun

Auto-generated profile, based on publicly available information

Chengchao Sun

Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital of Wenzhou Medical College, 2 Fuxue Lane, Wenzhou 325000, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2012 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
XMXiaoning Mou
Xiaoning Mou
YWYuanbo Wu
Yuanbo Wu
HCHenghua Cao
Henghua Cao
QMQingzhang Meng
Qingzhang Meng
QWQihui Wang
Qihui Wang
HZHao Zhang
Hao Zhang
Introduction: Down syndrome (DS), a major cause of mental retardation, is caused by trisomy of some or all of human chromosome 21 and includes three basic karyotypes: trisomy 21, translocation, and mosaicism. The derivation of DS-specific induced pluripotent stem cells (iPSCs) provides us novel DS models that can be used to determine the DS mechanism and to devise therapeutic approaches for DS patients. Methods: In the present study, fibroblasts from patients with DS of various karyotypes were reprogrammed into iPSCs via the overexpression of four factors: OCT4, SOX2, KLF4, and c-MYC, by using lentiviral vectors. The abilities of the iPSC-DS in the self-renewal and pluripotency in vitro and in vivo were then examined. Results: The iPSC-DS showed characteristics similar to those of human embryonic stem cells, particularly the morphology, surface marker (SSEA4, TRA-1-60, and TRA-1-81) expression, pluripotent-specific transcription-factor expression levels, and methylation status of the OCT4 promoter. The pluripotency of iPSC-DS was also tested in vitro and in vivo. Embryoid bodies were formed and showed the expression of differentiated markers for three germ layers. Furthermore, iPSC-DS formed classic teratomas when injected into nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice. Conclusions: iPSCs were generated from patients with DS. The iPSCs derived from different types of DS may be used in DS modeling, patient-care optimization, drug discovery, and eventually, autologous cell-replacement therapies.

10 April 2010 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
QYQi Yin
Qi Yin
PJPeifeng Jin
Peifeng Jin
XLXuebin Liu
Xuebin Liu
HWHua Wei
Hua Wei
XLXiaoming Lin
Xiaoming Lin
YWYingjie Wei
Yingjie Wei

1 February 2013
Verified
Journal Article
Closed access
CCchi chuang
chi chuang
ZHZhi-Feng He
Zhi-Feng He
YLYu Liu
Yu Liu
XLXiao-Ming Lin
Xiao-Ming Lin
CSCheng-Chao Sun
Cheng-Chao Sun
To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.